Active Biotech AB (ST:ACTI) — Stock Price

Skr3.90 SEK
▼ -4.06% today

Active Biotech AB (ST:ACTI) is currently trading at Skr3.90 SEK, down 4.06% today. Over the past 52 weeks, shares have ranged between Skr0.04 and Skr7.20. This page tracks Active Biotech AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see ACTI operating cash flow.

Active Biotech AB (ACTI) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Active Biotech AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Active Biotech AB Income Statement — Revenue, Profit & Earnings by Year

Active Biotech AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr0.00 Skr0.00 Skr0.00 Skr0.00 Skr6.22 Million
Cost of Revenue Skr1.60 Million Skr1.64 Million Skr1.68 Million Skr1.49 Million Skr1.28 Million
Gross Profit Skr-1.60 Million Skr-1.64 Million Skr-1.68 Million Skr-1.49 Million Skr-1.28 Million
Research & Development Skr25.20 Million Skr26.67 Million Skr32.54 Million Skr42.82 Million Skr34.54 Million
SG&A Skr12.36 Million Skr13.20 Million Skr13.90 Million Skr15.06 Million Skr15.25 Million
Total Operating Expenses Skr36.00 Million Skr39.80 Million Skr46.50 Million Skr57.89 Million Skr49.78 Million
Operating Income Skr-37.60 Million Skr-39.80 Million Skr-46.48 Million Skr-57.89 Million Skr-49.78 Million
EBITDA Skr-36.00 Million Skr-38.30 Million Skr-43.89 Million Skr-56.67 Million Skr-48.52 Million
EBIT Skr-37.60 Million Skr-39.90 Million Skr-45.56 Million Skr-58.17 Million Skr-49.80 Million
Interest Expense Skr113.00K Skr177.00K Skr238.00K Skr206.00K Skr26.00K
Income Before Tax Skr-37.30 Million Skr-39.40 Million Skr-45.80 Million Skr-58.37 Million Skr-49.83 Million
Income Tax Expense — — Skr-45.80 Million Skr319.00K Skr58.00K
Net Income Skr-37.30 Million Skr-39.40 Million Skr-45.80 Million Skr-58.69 Million Skr-49.88 Million

Active Biotech AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Active Biotech AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr70.20 Million Skr43.20 Million Skr44.05 Million Skr51.01 Million Skr56.80 Million
Total Current Assets Skr67.60 Million Skr39.20 Million Skr38.71 Million Skr44.12 Million Skr55.86 Million
Cash & Equivalents Skr65.10 Million Skr27.39 Million Skr36.22 Million Skr41.80 Million Skr53.13 Million
Short-term Investments — — — — —
Net Receivables Skr2.50 Million Skr9.50 Million Skr1.25 Million Skr947.00K Skr1.19 Million
Inventory — — Skr-2.50K — —
Property, Plant & Equipment Skr2.00 Million Skr3.35 Million Skr4.72 Million Skr6.30 Million Skr945.00K
Goodwill — — Skr-199.80K — —
Total Liabilities Skr14.60 Million Skr11.13 Million Skr13.38 Million Skr16.49 Million Skr10.13 Million
Total Current Liabilities Skr14.50 Million Skr8.90 Million Skr10.38 Million Skr12.06 Million Skr9.90 Million
Long-term Debt Skr100.00K Skr1.53 Million Skr3.00 Million Skr4.40 Million Skr200.00K
Net Debt Skr-63.36 Million Skr-24.22 Million Skr-31.67 Million Skr-35.76 Million Skr-52.15 Million
Total Stockholder Equity Skr55.60 Million Skr32.07 Million Skr30.67 Million Skr34.51 Million Skr46.67 Million
Retained Earnings Skr-3.52 Billion Skr-3.48 Billion Skr-3.44 Billion Skr-3.40 Billion Skr-3.34 Billion

Active Biotech AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Active Biotech AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-32.40 Million Skr-40.40 Million Skr-45.74 Million Skr-54.85 Million Skr-46.17 Million
Capital Expenditures Skr32.40 Million Skr0.00 Skr0.00 Skr245.00K Skr0.00
Free Cash Flow Skr-32.40 Million Skr-40.40 Million Skr-45.74 Million Skr-55.09 Million Skr-46.17 Million
Investing Cash Flow — — Skr0.00 Skr-245.00K Skr-200.00K
Financing Cash Flow Skr70.10 Million Skr31.60 Million Skr40.16 Million Skr43.76 Million Skr73.09 Million
Dividends Paid — — — — —
Stock-Based Compensation Skr0.00 Skr13.00K Skr172.00K Skr690.00K Skr284.00K
Depreciation Skr1.60 Million Skr1.64 Million Skr1.68 Million Skr1.50 Million Skr1.28 Million
Change in Cash Skr37.70 Million Skr-8.80 Million Skr-5.58 Million Skr-11.34 Million Skr26.92 Million

Active Biotech AB Earnings History — EPS Actual vs. Analyst Estimates

Track Active Biotech AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 20, 2026 -0.38 — —
May 07, 2026 0.00 — —
Feb 12, 2026 -0.01 — —
Nov 06, 2025 0.00 — —
Aug 21, 2025 -0.01 — —
May 08, 2025 -0.01 — —
Feb 13, 2025 -0.01 — —
Oct 21, 2024 -0.01 — —